InsidersTradesSigma
Follow the NOXOPHARM LIMITED stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the oversight of ASX. Market capitalisation: €28.9m. The latest transaction was disclosed on 1 June 2026 (Other). Every trade is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
NOXOPHARM LIMITED es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para el cáncer y otras enfermedades graves. Cotiza en el mercado XASX.